New Key Statistics Module, Z-Score and F-Score
TSX:HLS Key Ratios
Market Cap C$ M | 122.40 |
Enterprise Value C$ M | 192.35 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.09 |
Price/Sales | 1.56 |
Price/Free Cash Flow | 7.41 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | 79.00 |
EPS (TTM) C$ | -1.02 |
Beneish M-Score | -3.57 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -10.00 |
y-y EBITDA Growth Rate % | 9.80 |
EV-to-EBIT | -14.04 |
EV-to-EBITDA | 8.41 |
PEG | -- |
Shares Outstanding M | 31.79 |
Net Margin (%) | -40.92 |
Operating Margin % | -16.42 |
Pre-tax Margin (%) | -34.55 |
Quick Ratio | 1.69 |
Current Ratio | 2.02 |
ROA % (ttm) | -11.63 |
ROE % (ttm) | -25.07 |
ROIC % (ttm) | -6.52 |
Dividend Yield % | -- |
Altman Z-Score | -0.56 |
TSX:HLS Number of Guru Trades
TSX:HLS Volume of Guru Trades
Gurus Latest Trades with TSX:HLS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSX:HLS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HLS Therapeutics Inc Insider Transactions
No Available Data